User contributions
For
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)
- 11:21, 12 January 2018 (diff | hist) . . (0) . . DMAE (current)
- 11:20, 12 January 2018 (diff | hist) . . (-3,281) . . DMAE
- 08:29, 12 January 2018 (diff | hist) . . (+6) . . Iron metabolism anomalies (current)
- 08:27, 12 January 2018 (diff | hist) . . (+1,842) . . Iron metabolism anomalies
- 06:59, 12 January 2018 (diff | hist) . . (+1,000) . . Autophagy (current)
- 17:50, 13 November 2017 (diff | hist) . . (+1,840) . . MMP-9
- 16:30, 13 November 2017 (diff | hist) . . (+1,747) . . MMP-9
- 16:23, 13 November 2017 (diff | hist) . . (+6) . . MMP-9
- 16:20, 13 November 2017 (diff | hist) . . (+1,210) . . MMP-9
- 16:12, 13 November 2017 (diff | hist) . . (+6) . . MMP-9
- 16:10, 13 November 2017 (diff | hist) . . (+1,106) . . MMP-9
- 16:04, 13 November 2017 (diff | hist) . . (+1,267) . . MMP-9
- 15:49, 13 November 2017 (diff | hist) . . (+1,813) . . N MMP-9 (Created page with "Key concepts in ALS == Inhibition == ''Ischemic stroke is a leading cause of disability worldwide. In cerebral ischemia there is an enhanced expression of matrix metallo...")
- 14:55, 13 November 2017 (diff | hist) . . (+24) . . Sulforaphane
- 10:23, 13 November 2017 (diff | hist) . . (+40) . . Plan for an Integral Clinical Trial
- 10:17, 13 November 2017 (diff | hist) . . (+118) . . Plan for an Integral Clinical Trial
- 10:08, 13 November 2017 (diff | hist) . . (+138) . . Plan for an Integral Clinical Trial
- 10:01, 13 November 2017 (diff | hist) . . (+8) . . Sulforaphane
- 16:19, 12 November 2017 (diff | hist) . . (+8) . . Sulforaphane
- 16:15, 12 November 2017 (diff | hist) . . (+20) . . Sulforaphane
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)